Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers (NicRed)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- generally healthy
- between the ages of 15-25
- use nicotine or tobacco products between 1-15 days/month for at least 6 months
- smokes at least 5 cigarettes/month
- no unstable or significant medical or psychiatric conditions
- breath alcohol value=0.000
- able to provide contact information for two individuals who can corroborate smoking status
Exclusion Criteria:
- use of illegal drugs as measured by urine drug screen (excluding THC)
- serious quit attempt in the past 3 months
- plans to quit smoking in the next 2 months
- current use of nicotine replacement therapy or other tobacco cessation products
- inability to attend all required experimental sessions
- blood pressure >160/100 mmHg
- pregnant, trying to become pregnant, or breastfeeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: NNC, INC, VLNC
Normal Nicotine Content (NNC), Intermediate Nicotine Content (INC), Very Low Nicotine Content (VLNC)
|
cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield
Other Names:
|
|
Experimental: NNC, VLNC, INC
Normal Nicotine Content, Very Low Nicotine Content, Intermediate Nicotine Content
|
cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield
Other Names:
|
|
Experimental: INC, VLNC, NNC
Intermediate Nicotine Content, Very Low Nicotine Content, Normal Nicotine Content
|
cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield
Other Names:
|
|
Experimental: INC, NNC, VLNC
Intermediate Nicotine Content, Normal Nicotine Content, Very Low Nicotine Content
|
cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield
Other Names:
|
|
Experimental: VLNC, NNC, INC
Very Low Nicotine Content, Normal Nicotine Content, Intermediate Nicotine Content
|
cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield
Other Names:
|
|
Experimental: VLNC, INC, NNC
Very Low Nicotine Content, Intermediate Nicotine Content, Normal Nicotine Content
|
cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield
Other Names:
cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective reactions to fixed doses of tobacco smoke
Time Frame: Immediately after puff administration of each study cigarette
|
Smoking Effects Questionnaire ratings following administration of puffs for NNC, INC, and VLNC cigarettes
|
Immediately after puff administration of each study cigarette
|
|
Cigarette choice
Time Frame: 30 minutes after sampling all 3 study cigarettes
|
Participants will choose which of the three cigarettes they prefer to smoke by ranking each of the three cigarette conditions using a 1-3 scale where 1 is the cigarette that they most desire to smoke and 3 is the cigarette that they least desire to smoke.
|
30 minutes after sampling all 3 study cigarettes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mood and Affect
Time Frame: Immediately after puff administration of each study cigarette
|
The Positive and Negative Affect Schedule (PANAS)
|
Immediately after puff administration of each study cigarette
|
|
Mood and Affect
Time Frame: Immediately after puff administration of each study cigarette
|
Minnesota Nicotine Withdrawal Scale (MNWS)
|
Immediately after puff administration of each study cigarette
|
|
Smoking topography - Change in Carbon Monoxide (CO) values (in parts per million, ppm) following puff administration
Time Frame: Immediately after puff administration of each study cigarette
|
CO values (in ppm) will be obtained using a handheld CO monitor prior to puff administration and 5 minutes after completion of cigarette puff administration.
The difference in values will provide a CO boost value
|
Immediately after puff administration of each study cigarette
|
|
Smoking topography - number of puffs
Time Frame: During self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)
|
number of puffs
|
During self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)
|
|
Smoking topography - interpuff interval
Time Frame: During self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)
|
Interpuff interval (in seconds) will be calculated using video recordings of self-administration of chosen cigarette
|
During self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Chemically-Induced Disorders
- Substance-Related Disorders
- Tobacco Use Disorder
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Cholinergic Agents
- Ganglionic Stimulants
- Nicotinic Agonists
- Cholinergic Agonists
- Nicotine
Other Study ID Numbers
Other Study ID Numbers
- Pro00075882
- R01DA042532 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.